Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 37 Lymphoma, T-Cell, Cutaneous 15 Sezary Syndrome 14 Mycosis Fungoides 14 Lymphoma, Non-Hodgkin 12 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, Follicular 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large-Cell, Immunoblastic 11 Lymphoma, B-Cell, Marginal Zone 11 Hodgkin Disease 11 Lymphoma, Mantle-Cell 10 Lymphoma 10 Burkitt Lymphoma 10 Carcinoma, Merkel Cell 9 Recurrence 8 Leukemia, Myeloid, Acute 8 Breast Neoplasms 8 Skin Neoplasms 7 Multiple Myeloma 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia, Hairy Cell 7 Dendritic Cell Sarcoma, Interdigitating 7 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Myeloproliferative Disorders 6 Myelodysplastic Syndromes 6 Leukemia, Myelomonocytic, Chronic 6

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Melphalan 9 Interleukin-2 9 CTLA-4 Antigen 8 tebentafusp 7 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Blood Specimen Collection 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 trametinib 3 sotrastaurin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uveal Melanoma × Radiotherapy × Dermatologic × Clear all

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡